-
South Africa: Ivermectin Study Boosts Medical Regulator's Court Defence
GroundUp, 8 March 2021
The first substantial peer-reviewed clinical trial of the drug against Covid-19 finds no evidence that it is a wonder medicine Read more »
-
South Africa: Sahpra Decision On Ivermectin Shifts Heavy Responsibility to Doctors
spotlight, 29 January 2021
The South African Health Products Regulatory Authority (SAHPRA) this week announced that doctors will be able to apply for access to the experimental COVID-19 treatment ivermectin… Read more »
-
South Africa: Covid-19 and Ivermectin - SAHPRA Reaches Settlement With Afriforum
GroundUp, 1 February 2021
A court challenge aimed at legalising the use of ivermectin in the treatment of Covid-19 -- and giving doctors unfettered discretion on how to administer it -- has been settled. Read more »
-
South Africa: Ivermectin and Covid-19 - SA Drug Regulator Allows Controlled, Compassionate Access
Daily Maverick, 27 January 2021
South Africa's medicines regulator finds middle ground to authorise 'compassionate use' of ivermectin, whilst still stating that there is not yet sufficient evidence for full… Read more »
-
South Africa: Ivermectin and Covid-19 - Why It's Promising but Why We Need to Be Cautious
GroundUp, 14 January 2021
Medicines are only approved for use by the South African Health Products Regulatory Authority when there is sufficient evidence that their benefits outweigh their risks. Read more »
Ivermectin Study Boosts South African Regulator's Court Defence
Four court cases have been launched against the South African Health Products Regulatory Authority (SAHPRA) to compel the regulator to make ivermectin available for the treatment of Covid-19. Among the applicants are lobby group AfriForum and the African Christian Democratic Party. However, not a single peer-reviewed clinical trial in a leading medical journal has shown that ivermectin is effective against coronaviruses, writes Elsabé Brits for GroundUp. Ivermectin is an anti-parasitic drug, used to treat river blindness.
The only ivermectin products approved by SAHPRA are for veterinary use. Now the results of a trial published in the prestigious Journal of American Medical Association (JAMA) should strengthen SAHPRA's case.
Among 398 adults with mild Covid-19 symptoms, a five-day course of ivermectin compared with a placebo did not significantly improve symptoms. Previously, the SAHPRA said that doctors could apply for access to the experimental Covid-19 treatment ivermectin in terms of section 21 of the Medicines Act. This, however, shifted responsibility for the treatment's efficacy on doctors.
InFocus
-
The South African Health Products Regulatory Authority (SAHPRA) has announced that doctors will be able to apply for access to the experimental COVID-19 treatment ivermectin in ... Read more »
-
The Global Advisory Committee on Vaccine Safety Covid-19 Subcommittee has met virtually to review available information and data on reports of influenza-like illness in health-care ... Read more »
-
As of August 21, 2022, confirmed cases of Covid-19 from 55 African countries reached 12,126,067 while 373,195,217 vaccinations have been administered across ... Read more »
